Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Feikang granules ameliorate pulmonary inflammation in the rat model of chronic obstructive pulmonary disease via TLR2/4-mediated NF-κB pathway

Fig. 3

Effects of Feikang granules on inflammatory cytokine changes in bronchoalveolar lavage fluid. Cytokines IL-1β, TNF-α, IL-6 and IL-17 were measured. The data are shown as the mean ± the standard deviation (SD). p < 0.05 and p < 0.01 indicate statistically significant differences compared to the model group; ##p < 0.01 indicate a statistically significant difference in model group compared with normal control group. These results were from the rats in each group of control (n = 4), COPD (n = 6), low dose (n = 5), middle dose (n = 5), high does (n = 5) of Feikang granules and dexamethasone (n = 5)

Back to article page